Optimisation of the analysis of anti-influenza drugs in wastewater and surface water

We optimised the simultaneous analysis of four analytes, namely three anti-influenza drugs (oseltamivir (OS), zanamivir (ZAN) and amantadine (AMN)) and one metabolite of OS (oseltamivir carboxylate (OC)), in sewage treatment plant (STP) influent and effluent by verifying the types and conditions of solid phase extraction (SPE) appropriate for LC-MS/MS analysis. In summary, these target analytes were extracted from aqueous samples (30–50 mL) by using strong cation-exchange SPE cartridges (500 mg adsorbent) under acidic conditions (pH 3–4). After washing of the cartridges with acidified water (pH 3.0, 3 mL) and methanol (3 mL), the analytes were eluted with a mixed solvent (2 mL) of 10% (v/v) triethylamine in a 1:1 (v/v) mixture of acetone and water. Application of this technique to the target compounds should yield a comprehensive understanding of the occurrence and fate of anti-influenza drugs in the water environment.

[1]  N. Nakada,et al.  Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak. , 2012, Environmental science & technology.

[2]  S. Weigel,et al.  Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry , 2011, Analytical and Bioanalytical Chemistry.

[3]  J. Fick,et al.  Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards , 2011, PloS one.

[4]  J. Farrar,et al.  Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS. , 2011, Bioanalysis.

[5]  N. Nakada,et al.  Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants. , 2010, Chemosphere.

[6]  Jerker Fick,et al.  Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments. , 2010, Chemosphere.

[7]  J. B. Ellis,et al.  Antiviral pandemic risk assessment for urban receiving waters. , 2010, Water science and technology : a journal of the International Association on Water Pollution Research.

[8]  Ralf Schulz,et al.  Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? , 2010, Environmental science & technology.

[9]  Dong Chen,et al.  Determination of 76 pharmaceutical drugs by liquid chromatography-tandem mass spectrometry in slaughterhouse wastewater. , 2009, Journal of chromatography. A.

[10]  Vimal Kumar,et al.  Rapid determination of free and conjugated estrogen in different water matrices by liquid chromatography-tandem mass spectrometry. , 2009, Chemosphere.

[11]  Hiroaki Tanaka,et al.  Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan , 2009, Environmental health perspectives.

[12]  N. Yamashita,et al.  Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants. , 2009, Environment international.

[13]  J. Fick,et al.  Detection of the Antiviral Drug Oseltamivir in Aquatic Environments , 2009, PloS one.

[14]  W. von Tümpling,et al.  The environmental fate of the antiviral drug oseltamivir carboxylate in different waters. , 2008, The Science of the total environment.

[15]  Mats Tysklind,et al.  Antiviral Oseltamivir Is not Removed or Degraded in Normal Sewage Water Treatment: Implications for Development of Resistance by Influenza A Virus , 2007, PloS one.

[16]  P. Grenni,et al.  Degradation of the antiviral drug oseltamivir carboxylate in surface water samples , 2007 .

[17]  Andrew C. Singer,et al.  Potential Risks Associated with the Proposed Widespread Use of Tamiflu , 2006, Environmental health perspectives.

[18]  C. Daughton.  Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. , 2002, Environmental health perspectives.

[19]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002, Environmental science & technology.

[20]  J. Dunn,et al.  Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[21]  C. Dye,et al.  Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic. , 2012, The Science of the total environment.

[22]  Peter Oefner,et al.  BIOANALYSIS , 2008, Electrophoresis.